Press release
Transformative Trends Impacting the Antifungals Market Landscape: Strategic Collaborations For Expansion In The Anti-Infective Drugs Market
Antifungals
How Large Will the Antifungals Market Size By 2025?
Recent years have seen robust growth in the antifungals market size. Its growth is projected to surge from $27.16 billion in 2024 to $29.6 billion in 2025, marking a compound annual growth rate (CAGR) of 9.0%. The historic period's growth can be linked to factors like the prevalence of fungal diseases, an aging population, advancements in healthcare infrastructure, and increased awareness and education.
How Big Is the Antifungals Market Size Expected to Grow by 2029?
The market for antifungals is forecasted to experience robust expansion in the approaching years, increasing to a value of "$41.2 billion by 2029", with a compound annual growth rate (CAGR) of 8.6%. Factors contributing to this growth during the projected period include the rise of new fungal strains, regulatory greenlights, escalating international health issues, heightened healthcare expenditure, and improved patient understanding and consciousness. Key trends anticipated over the forecast timeframe encompass research and development efforts, telemedicine and e-health initiatives, progress in the development of antifungal medications, and strategic collaborations and alliances.
View the full report here:
https://www.thebusinessresearchcompany.com/report/antifungals-global-market-report
Which Key Market Drivers Powering Antifungals Market Expansion and Growth?
The antifungals market is projected to grow due to the rising instances of fungal infections. These infections are medical conditions that stem from the infestation and proliferation of fungi in or on the body and can impact an assortment of body parts, including skin, nails, lungs, and mucous membranes. This rise in fungal infections can be attributed to several factors such as an increasing population of immunocompromised individuals, climate change providing ideal conditions for fungal development, extensive use of broad-spectrum antibiotics disrupting natural microbiomes, inadequate hygiene, urbanization, and the rising occurrences of chronic diseases like diabetes, susceptible individuals to fungal infections. Antifungals are pivotal in managing fungal diseases by curbing the growth and reproduction of fungi, either by interfering with their cell wall or membrane, obstructing crucial enzymatic processes, or meddling with their capability to synthesize critical components, which in turn diminishes the fungal load, eases symptoms, and prevents the infection from proliferating within the body. For example, the International Society For Infectious Diseases, a non-profit organization in the US, reported an annual occurrence of 6.5 million invasive fungal infections in September 2024, tied with around 3.8 million deaths, out of which 2.5 million (68%; range 35-90%) were directly caused by these infections. Therefore, the escalating instances of fungal infections are expected to push the antifungals market's growth.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2442&type=smp
What Long-Term Trends Will Define the Future of the Antifungals Market?
Pharmaceutical creators and producers are enhancing their various sectors like research and development, marketing, and manufacturing by joining hands with other firms and research institutions. This move is used to widen their range of products. Therefore, corporations in the anti-infective drugs market should regard strategic alliances as a crucial approach to diversify their offerings and outreach, promoting enhanced revenue and maintaining market competitiveness.
What Are the Emerging Segments in the Antifungals Market?
The antifungals market covered in this report is segmented -
1) By Drug Type: Echinocandins, Azoles, Polyenes, Allylamines
2) By Route of Administration: Oral, Parenteral, Topical
3) By End users: Hospitals & Clinics, Dermatology clinics, Other Users
Subsegments:
1) By Echinocandins: Caspofungin, Micafungin, Anidulafungin
2) By Azoles: Fluconazole, Itraconazole, Voriconazole, Posaconazole, ket*oconazole
3) By Polyenes: Amphotericin B, Nystatin
4) By Allylamines: Terbinafine, Naftifine
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=2442&type=smp
Who Are the Global Leaders in the Antifungals Market?
Major companies operating in the antifungals market include Pfizer Inc., Novartis International AG, Merck & Co. Inc., Bayer AG, Abbott Laboratories, Sanofi S.A., Kramer Laboratories Inc., GlaxoSmithKline plc, Gilead Sciences Inc., Basilea Pharmaceutica AG, Sigma-Aldrich, Astellas Pharma Inc., Janssen Pharmaceutica NV, Zydus Cadila Healthcare Ltd., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Sumitomo Dainippon Pharma Co. Ltd., Scynexis Inc., Mayne Pharma Inc., Cosmo Pharmaceuticals NV, Leadiant Biosciences Inc, Glenmark Pharmaceuticals Limited, Cidara Therapeutics, MATINAS BIOPHARMA, Mylan N.V., Perrigo Company plc, Wockhardt Ltd., Lupin Limited, Dr. Reddy's Laboratories Ltd, Torrent Pharmaceuticals Ltd., Hikma Pharmaceuticals PLC, Mayne Pharma Group Limited, Fresenius Kabi AG, Baxter International Inc., Akorn Operating Company LLC, Amphastar Pharmaceuticals Inc., Mylan Institutional LLC, West-Ward Pharmaceuticals Corp., Gland Pharma Limited, Aurobindo Pharma Limited
Which are the Top Profitable Regional Markets for the Antifungals Industry?
North America was the largest region in the drugs for antifungals market in 2024. The Middle East is expected to be the fastest-growing region in the antifungals market. The regions covered in the antifungals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2442
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795,
Asia +44 7882 955267 & +91 8897263534,
Europe +44 7882 955267
Email:saumyas@tbrc.info
The Business Research Company -www.thebusinessresearchcompany.com
Follow Us On:
LinkedIn:https://in.linkedin.com/company/the-business-research-company
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Transformative Trends Impacting the Antifungals Market Landscape: Strategic Collaborations For Expansion In The Anti-Infective Drugs Market here
News-ID: 4183882 • Views: …
More Releases from The Business Research Company
In-Depth Examination of Segments, Industry Developments, and Key Players in the …
The automotive laser projection market is poised for remarkable expansion in the coming years, driven by rapid advancements in vehicle technology and increasing demand for enhanced driver assistance features. This sector is becoming a focal point for innovations that promise to transform vehicular lighting and safety systems, offering new experiences for drivers and passengers alike. Let's delve into the market's projected size, key players, emerging trends, and segmentation to better…
Analysis of Key Market Segments Driving the Automotive Interior Leather Market
The automotive interior leather market is positioned for notable expansion in the coming years, driven by evolving consumer preferences and advancements in material technology. This report explores the market's expected growth, leading players, key trends, and segmentation to provide a clear understanding of what lies ahead for this sector.
Forecasted Market Size and Growth Trajectory of the Automotive Interior Leather Market
The size of the automotive interior leather market is projected…
Leading Companies Fueling Innovation and Growth in the Automotive Idler Arm Mark …
The automotive idler arm market is set for steady advancement over the coming years, driven by evolving vehicle technologies and growing industry demands. As the automotive landscape shifts toward more efficient and safer steering components, this market is expected to experience consistent growth and innovation.
Market Size and Expansion Outlook for the Automotive Idler Arm Market
Forecasts indicate that the automotive idler arm market will reach $5.97 billion by 2030, expanding…
Market Drivers Analysis: The Impact of Recent Innovations on the Automotive Hybr …
The automotive hybrid starter generator market is positioned for significant expansion as the automotive sector continues its shift toward electrification and efficiency. Driven by evolving regulations and technological innovations, this market is set to experience steady growth, offering ample opportunities for manufacturers and stakeholders. Let's explore the market size projections, key players, emerging trends, and segmentation that define this dynamic field.
Projected Market Size and Growth Trajectory of the Automotive Hybrid…
More Releases for Pharma
Schizophrenia Market Gains Momentum with Expanding Pipeline and Investment Poten …
The Key Schizophrenia Companies in the market include - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Acadia Pharmaceuticals, Boehringer Ingelheim, Cerevel Therapeutics, AstraZeneca, Eli Lilly and Company, Karuna Therapeutics, Neurocrine Biosciences, and others.
DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2036" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed…
Schizophrenia Market: Expanding Revenue Landscape to 2034 - DelveInsight | Teva …
The Key Schizophrenia Companies in the market inlclude - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Reviva Pharmaceuticals, and others.
DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2034" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed insights into the disease, including historical and projected epidemiology, helping stakeholders understand the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
